Moreover, CKS2 expression in cervical cancer patients diagnosed to be in clinical stage II (11.097 ± 1.700) was higher compared with that in cervical cancer patients with clinical stage I (8.258 ± 2.175) (P < 0.001) (Figure 4). This evidence concerns the gene CKS2 and cervical cancer.